Connor, Clark & Lunn Investment Management Ltd. Ani Pharmaceuticals Inc Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 46,750 shares of ANIP stock, worth $2.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,750
Previous 15,442
202.75%
Holding current value
$2.8 Million
Previous $853,000
266.82%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ANIP
# of Institutions
239Shares Held
20.2MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$70.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$49 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.736KShares$44 Million3.53% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$43.3 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.04B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...